Rocket Pharmaceuticals Reverse Merges with Inotek Pharmaceuticals to Advance Gene Therapies
By Natasha Piper
Pharma Deals Review: Vol 2017 Issue 9 (Table of Contents)
Published: 22 Sep-2017
DOI: 10.3833/pdr.v2017.i9.2275 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Start-up company, Rocket Pharmaceuticals, has agreed to reverse merge with troubled Inotek Pharmaceuticals to advance its pipeline of first-in-class gene therapies to treat rare diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS